angiotensin ii has been researched along with 8,11,14-eicosatrienoic acid in 22 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (9.09) | 18.7374 |
1990's | 4 (18.18) | 18.2507 |
2000's | 5 (22.73) | 29.6817 |
2010's | 11 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cunnane, SC; Horrobin, DF; Karmazyn, M; Manku, MS | 1 |
Douglas, JG; Goldthwait, DA; Hopfer, U; Madhun, ZT; McKay, D | 1 |
Douglas, JG; Hopfer, U; Madhun, ZT; Romero, MF | 1 |
Broughton Pipkin, F; O'Brien, PM | 1 |
Andreatta-van Leyen, S; Douglas, JG; Khosla, MC; Romero, MF | 1 |
Abe, K; Abe, M; Arima, S; Endo, Y; Ito, S; Ogawa, S; Omata, K; Takeuchi, K; Tsunoda, K; Yaoita, H | 1 |
Arima, S; Endo, Y; Ito, O; Ito, S; Kohagura, K; Omata, K | 1 |
Capdevila, JH; Falck, JR; Imig, JD; Wei, S; Zhao, X | 1 |
Barbosa-Sicard, E; Dechend, R; Fiebeler, A; Haller, H; Honeck, H; Kaergel, E; Kirsch, T; Luft, FC; Markovic, M; Muller, DN; Park, JK; Rothe, M; Schunck, WH; Shagdarsuren, E; Theuer, J; Wellner, M | 1 |
Chabrashvili, T; Wang, D; Wilcox, CS | 1 |
Endo, Y; Fujita, T; Horita, S; Kita, Y; Li, Y; Seki, G; Shimizu, T; Suzuki, M; Yamada, H; Yamazaki, O | 1 |
Certíková Chábová, V; Cervenka, L; Falck, JR; Hammock, BD; Imig, JD; Kompanowska-Jezierska, E; Kopkan, L; Kramer, HJ; Kujal, P; Sadowski, J; Vanecková, I; Vanourková, Z; Vernerová, Z; Walkowska, A | 1 |
Campbell, WB; Falck, JR; Gauthier, KM; Kopf, PG; Zhang, DX | 1 |
Cosic, A; Drenjancevic, I; Falck, JR; Kibel, A; Mihaljevic, Z; Novak, S | 1 |
Chen, C; He, Z; Hoopes, SL; Wang, DW; Wen, Z; Zeldin, DC; Zhang, X | 1 |
Bürgelová, M; Červenka, L; Hammock, BD; Husková, Z; Hwang, SH; Imig, JD; Melenovský, V; Sadowski, J; Škaroupková, P; Sporková, A | 1 |
Cai, Q; Chen, J; Huang, H; Liu, X; Liu, Y; Wang, J; Zhang, K | 1 |
Červenka, L; Doleželová, Š; Falck, JR; Husková, Z; Imig, JD; Jíchová, Š; Kompanowska-Jezierska, E; Kopkan, L; Kramer, HJ; Kujal, P; Neckář, J; Reddy, RN; Sadowski, J; Vernerová, Z | 1 |
Chen, J; Huang, J; Lai, J; Wang, DW; Xu, X; Zhou, C; Zhu, F | 1 |
Chen, X; Gao, Y; Huang, X; Wang, Y; Zhang, Z | 1 |
He, GW; Liu, XC; Mak, SK; Sun, WT; Yang, Q; Yu, CM | 1 |
Campbell, WB; Falck, JR; Gauthier, KM; Kriska, T; Shah, AJ | 1 |
22 other study(ies) available for angiotensin ii and 8,11,14-eicosatrienoic acid
Article | Year |
---|---|
Prolactin and zinc effects on rat vascular reactivity: possible relationship to dihomo-gamma-linolenic acid and to prostaglandin synthesis.
Topics: 8,11,14-Eicosatrienoic Acid; Angiotensin II; Animals; Arachidonic Acids; Fatty Acids, Unsaturated; Hydrocortisone; Lithium; Male; Mesentery; Norepinephrine; Potassium; Prolactin; Prostaglandins; Prostaglandins E; Rats; Zinc | 1979 |
An epoxygenase metabolite of arachidonic acid mediates angiotensin II-induced rises in cytosolic calcium in rabbit proximal tubule epithelial cells.
Topics: 8,11,14-Eicosatrienoic Acid; Angiotensin II; Animals; Arachidonic Acid; Arachidonic Acids; Calcium; Calcium Channels; Cells, Cultured; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; Cytosol; Ketoconazole; Kidney Tubules, Proximal; Male; Oxygenases; Rabbits; Signal Transduction | 1991 |
An epoxygenase metabolite of arachidonic acid 5,6 epoxy-eicosatrienoic acid mediates angiotensin-induced natriuresis in proximal tubular epithelium.
Topics: 8,11,14-Eicosatrienoic Acid; Angiotensin II; Animals; Arachidonic Acid; Arachidonic Acids; Calcium; Cells, Cultured; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; Epithelium; Kidney Tubules, Proximal; Natriuresis; Oxygenases; Phospholipases A; Rabbits; Second Messenger Systems; Sodium; Sodium-Potassium-Exchanging ATPase | 1991 |
The effect of essential fatty acid and specific vitamin supplements on vascular sensitivity in the mid-trimester of human pregnancy.
Topics: 8,11,14-Eicosatrienoic Acid; Angiotensin II; Blood Pressure; Fatty Acids, Essential; Female; Food, Fortified; Humans; Linoleic Acid; Linoleic Acids; Pregnancy; Pregnancy Trimester, Second; Vasoconstriction; Vitamins | 1983 |
Modulation of phospholipase A2 activity and sodium transport by angiotensin-(1-7).
Topics: 8,11,14-Eicosatrienoic Acid; Angiotensin I; Angiotensin II; Animals; Biological Transport; Cells, Cultured; Kidney Tubules, Proximal; Lysophosphatidylcholines; Male; Peptide Fragments; Phospholipases A; Phospholipases A2; Rabbits; Sodium | 1993 |
Possible role of P-450 metabolite of arachidonic acid in vasodilator mechanism of angiotensin II type 2 receptor in the isolated microperfused rabbit afferent arteriole.
Topics: 8,11,14-Eicosatrienoic Acid; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arachidonic Acid; Arterioles; Benzimidazoles; Biphenyl Compounds; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Endothelium, Vascular; Humans; Imidazoles; In Vitro Techniques; Kidney Glomerulus; Large-Conductance Calcium-Activated Potassium Channels; Male; Norepinephrine; Perfusion; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Calcium-Activated; Pyridines; Rabbits; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetraethylammonium; Tetrazoles; Vasoconstrictor Agents; Vasodilator Agents | 1997 |
Endogenous nitric oxide and epoxyeicosatrienoic acids modulate angiotensin II-induced constriction in the rabbit afferent arteriole.
Topics: 8,11,14-Eicosatrienoic Acid; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arterioles; Dose-Response Relationship, Drug; Enzyme Inhibitors; Imidazoles; Male; Miconazole; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pyridines; Rabbits; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Vasoconstriction; Vasoconstrictor Agents | 2000 |
Enhanced renal microvascular reactivity to angiotensin II in hypertension is ameliorated by the sulfonimide analog of 11,12-epoxyeicosatrienoic acid.
Topics: 8,11,14-Eicosatrienoic Acid; Angiotensin II; Animals; Arterioles; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; Drug Synergism; Hypertension; Kidney Cortex; Male; Microcirculation; Microsomes; Rats; Rats, Sprague-Dawley; Renal Circulation; Sulfonamides; Vasoconstriction | 2001 |
A peroxisome proliferator-activated receptor-alpha activator induces renal CYP2C23 activity and protects from angiotensin II-induced renal injury.
Topics: 8,11,14-Eicosatrienoic Acid; Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Arachidonic Acid; Blotting, Western; Chromatography, Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; Fenofibrate; Humans; Hypertension; Hypolipidemic Agents; Immunohistochemistry; Kidney; Kidney Diseases; Mass Spectrometry; NF-kappa B; Polymerase Chain Reaction; Rats; Receptors, Cytoplasmic and Nuclear; Renin; Transcription Factors; Vasoconstrictor Agents | 2004 |
Enhanced contractility of renal afferent arterioles from angiotensin-infused rabbits: roles of oxidative stress, thromboxane prostanoid receptors, and endothelium.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 8,11,14-Eicosatrienoic Acid; Angiotensin II; Animals; Arterioles; Bridged Bicyclo Compounds, Heterocyclic; Cyclic N-Oxides; Cyclooxygenase 2; Dose-Response Relationship, Drug; Endothelin-1; Endothelins; Endothelium, Vascular; Isoenzymes; Kidney; Male; Nitroarginine; Norepinephrine; Oxazoles; Oxidative Stress; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rabbits; Receptors, Thromboxane; RNA, Messenger; Spin Labels; Superoxides; Vascular Resistance; Vasoconstriction | 2004 |
Arachidonic acid metabolites inhibit the stimulatory effect of angiotensin II in renal proximal tubules.
Topics: 8,11,14-Eicosatrienoic Acid; Angiotensin II; Animals; Arachidonic Acid; Calcium; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Group IV Phospholipases A2; Kidney Tubules, Proximal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Phosphorylation; Receptor, Angiotensin, Type 1; Signal Transduction; Sodium-Bicarbonate Symporters | 2008 |
Combined inhibition of 20-hydroxyeicosatetraenoic acid formation and of epoxyeicosatrienoic acids degradation attenuates hypertension and hypertension-induced end-organ damage in Ren-2 transgenic rats.
Topics: 8,11,14-Eicosatrienoic Acid; Amides; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Drug Evaluation, Preclinical; Hydroxyeicosatetraenoic Acids; Hypertension; Male; Multiple Organ Failure; Norepinephrine; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Renal Circulation; Sulfones; Vasoconstrictor Agents | 2010 |
Angiotensin II regulates adrenal vascular tone through zona glomerulosa cell-derived EETs and DHETs.
Topics: 8,11,14-Eicosatrienoic Acid; Adrenal Glands; Aldosterone; Angiotensin II; Animals; Arachidonic Acid; Arteries; Cattle; Cells, Cultured; Dose-Response Relationship, Drug; Epoxide Hydrolases; In Vitro Techniques; Membrane Potentials; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Patch-Clamp Techniques; Potassium Channels; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents; Zona Glomerulosa | 2011 |
Hyperbaric oxygenation modulates vascular reactivity to angiotensin-(1-7) in diabetic rats: potential role of epoxyeicosatrienoic acids.
Topics: 8,11,14-Eicosatrienoic Acid; Amides; Angiotensin I; Angiotensin II; Animals; Aorta, Thoracic; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 2; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Enzyme Induction; Enzyme Inhibitors; Hyperbaric Oxygenation; Male; Oxidative Stress; Peptide Fragments; Rats, Sprague-Dawley; Steroid 16-alpha-Hydroxylase; Vascular Resistance; Vasoconstriction; Vasodilation; Vasodilator Agents | 2015 |
Cardiomyocyte-specific expression of CYP2J2 prevents development of cardiac remodelling induced by angiotensin II.
Topics: 8,11,14-Eicosatrienoic Acid; Angiotensin II; Animals; Cells, Cultured; Coculture Techniques; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; Disease Models, Animal; Hypertrophy, Left Ventricular; Male; Mice, Inbred C57BL; Mice, Transgenic; Myocytes, Cardiac; Oxidative Stress; PPAR gamma; Rats; Signal Transduction; Transcription Factor RelA; Ventricular Function, Left; Ventricular Remodeling | 2015 |
Inhibition of soluble epoxide hydrolase does not improve the course of congestive heart failure and the development of renal dysfunction in rats with volume overload induced by aorto-caval fistula.
Topics: 8,11,14-Eicosatrienoic Acid; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzoates; Disease Models, Animal; Drug Evaluation, Preclinical; Epoxide Hydrolases; Epoxy Compounds; Heart Failure; Kidney; Male; Myocardium; Peptide Fragments; Random Allocation; Rats; Renal Insufficiency; Renin-Angiotensin System; Ultrasonography; Urea | 2015 |
Apocynin improving cardiac remodeling in chronic renal failure disease is associated with up-regulation of epoxyeicosatrienoic acids.
Topics: 8,11,14-Eicosatrienoic Acid; Acetophenones; Aged; Angiotensin II; Animals; Cardio-Renal Syndrome; Cardiotonic Agents; Cell Line; Disease Models, Animal; Epoxide Hydrolases; Female; Fibrosis; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocytes, Cardiac; Rats, Sprague-Dawley; Stroke Volume; Up-Regulation; Ventricular Function, Left; Ventricular Remodeling | 2015 |
Epoxyeicosatrienoic acid analog attenuates the development of malignant hypertension, but does not reverse it once established: a study in Cyp1a1-Ren-2 transgenic rats.
Topics: 8,11,14-Eicosatrienoic Acid; Albuminuria; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Cytochrome P-450 CYP1A1; Hypertension, Malignant; Indoles; Kidney; Male; Peptide Fragments; Rats; Rats, Transgenic; Renin; Renin-Angiotensin System; Time Factors | 2016 |
CYP2J2-Derived EETs Attenuated Angiotensin II-Induced Adventitial Remodeling via Reduced Inflammatory Response.
Topics: 8,11,14-Eicosatrienoic Acid; Adventitia; Angiotensin II; Animals; Aorta; Blotting, Western; Cell Differentiation; Cell Movement; Cell Proliferation; Cells, Cultured; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; Fibroblasts; Gene Transfer Techniques; HEK293 Cells; Humans; Inflammation Mediators; Male; Mice, Inbred C57BL; Microscopy, Fluorescence; Rats, Inbred WKY; RNA Interference; Signal Transduction; Suppressor of Cytokine Signaling 3 Protein; Vascular Remodeling | 2016 |
Ophiopogonin D and EETs ameliorate Ang II-induced inflammatory responses via activating PPARα in HUVECs.
Topics: 8,11,14-Eicosatrienoic Acid; Angiotensin II; Cells, Cultured; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; NF-kappa B; PPAR alpha; Protein Transport; Saponins; Spirostans | 2017 |
Tetramethylpyrazine suppresses angiotensin II-induced soluble epoxide hydrolase expression in coronary endothelium via anti-ER stress mechanism.
Topics: 8,11,14-Eicosatrienoic Acid; Angiotensin II; Animals; Cells, Cultured; Coronary Vessels; Dose-Response Relationship, Drug; Endoplasmic Reticulum Stress; Endothelial Cells; Epoxide Hydrolases; In Vitro Techniques; Pyrazines; Sus scrofa; Tunicamycin; Vasodilation; Vasodilator Agents | 2017 |
Effect of Angiotensin II and ACTH on Adrenal Blood Flow in the Male Rat Adrenal Gland In Vivo.
Topics: 8,11,14-Eicosatrienoic Acid; Adrenal Glands; Adrenocorticotropic Hormone; Angiotensin II; Animals; Cyclooxygenase Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Eicosanoids; Endothelium, Vascular; Enzyme Inhibitors; Indomethacin; Injections, Intravenous; Male; Miconazole; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Receptors, Corticotropin; Regional Blood Flow; Signal Transduction | 2018 |